DEA Telemedicine Flexibilities: Controlled Substances Prescriptions Extended Through 2024 by Marlene M. Maheu, PhD
Legislation to Remove the In-Person Requirement for Telehealth & Telemedicine Reimbursement by Marlene M. Maheu, PhD
Temporary Extension of Telemedicine Prescription Rule Approved & Effective Immediately by Marlene M. Maheu, PhD
Telemedicine Performance Measures (Telehealth KPIS) Issued by American College of Physicians by Marlene M. Maheu, PhD
Ryan Haight Act Telemedicine: AHA Calls on DEA to Release Special Registration Now by Marlene M. Maheu, PhD
Eighty-Five % of Physicians Support Legislative Approvals for Suboxone Telemedicine by Marlene M. Maheu, PhD
Characteristics of Telemedicine Healthcare Fraud and Abuse as Defined by DOJ & OIG by Marlene M. Maheu, PhD
Discrepancies in Audio-Only Telemedicine Data May Affect Future Reimbursement Policy by Marlene M. Maheu, PhD
Opioid Crisis: Money, Telehealth Addiction Treatment with Suboxone Telemedicine & Tele-MAT by Marlene M. Maheu, PhD